- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02278679
Digital Rectal Exam Proficiency Tool (DiRECT)
Validation of the DiRECT Proficiency Tool
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
First, it will be validated on 120 anesthetized patients undergoing prostate surgery, comparing responses on the digital rectal exam clinical tool (DiRECT) from both expert and novice clinicians, with surgical pathology reports. The second phase of validation will involve the participation of standardized patients, medical students and MUTA (medical urology teaching associate). During a standardized patient exercise focusing on digital rectal exam in the University of Virginia School of Medicine curriculum, 160 second-year medical students will be given the DiRECT to document their examination. An attending physician will also attend the standardized patient exercise and document their examination for comparison with the medical students.
The third phase includes 8 residents and up to10 attendings in the Urology clinic, who will independently complete the DiRECT documenting their DRE in the course of usual care.
Comparison of faculty and student/trainee responses in all phases will be used for validation of the clinical tool for further use in medical education.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- Recruiting
- University of Virginia Health System, Dept of Urology
-
Contact:
- Tracey L Krupski, M.D.
- Phone Number: 434-924-0042
- Email: tlk6t@virginia.edu
-
Contact:
- Patricia Battle, LPN, CRC
- Phone Number: 434-924-5649
- Email: pya@virginia.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Subjects who are patients:
- Patients who are male and adults ≥ 30 years of age
- Standardized patients between the ages of 30-80 years participating in the University of Virginia School of Medicine activity for second-year students learning digital rectal exams
Subjects who are clinicians:
• Attending physician, resident physician, or medical student scrubbed in for a prostatectomy or cystectomy, seeing patients in urology clinic, or participating in the School of Medicine activity for second year students learning digital rectal exams
Exclusion Criteria:
List the criteria for exclusion
- Patients who do not have a prostate
- Patients with previous pelvic/perineal surgery
- Previously enrolled in this study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Anesthitized patient
First, it will be validated on 120 anesthetized patients undergoing prostate surgery comparing responses on the digital rectal exam clinical tool (DiRECT) from both expert and novice clinicians, with surgical pathology reports.
|
The DRE digital rectal exam is an essential component of physical examination, but physicians enter their residency having neither been appropriately exposed nor trained in performing DREs.
, the attending physician, resident physician(s), and medical student(s) will each perform a digital rectal exam on the subject, and independently document their examination on the DiRECT instrument.
|
|
Standardized patients
During a standardized patient exercise focusing on digital rectal exam in the University of Virginia School of Medicine curriculum, 160 second-year medical students will be given the DiRECT to document their examination.
An attending physician will also attend the standardized patient exercise and document their examination for comparison with the medical students.
|
|
|
Clinic patient
The third phase includes 8 residents and up to10 attendings in the Urology clinic, who will independently complete the DiRECT documenting their DRE in the course of usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Validate DiRECT tool
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tracey L Krupski, M.D., University of Virginia, Dept of Urology
- Study Chair: Raymond A Costabile, M.D., University of Virginia, Dept of Urology
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17658
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostatic Hyperplasia
-
University of CalgaryNot yet recruitingBenign Prostatic Hyperplasia | Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia With Outflow ObstructionCanada
-
GlaxoSmithKlineCompletedBenign Prostatic Hyperplasia
-
St. Joseph's Healthcare HamiltonOntario Ministry of Health and Long Term CareCompletedBenign Prostatic HyperplasiaCanada
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityNot yet recruitingBenign Prostatic Hyperplasia
-
Second Affiliated Hospital, School of Medicine,...RecruitingBenign Prostatic HyperplasiaChina
-
Jewish General HospitalNot yet recruitingBenign Prostatic Hyperplasia
-
Zenflow, Inc.RecruitingBenign Prostatic HyperplasiaAustralia, New Zealand
-
REMD Medical TechnologyRenJi Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Sun Yat-Sen... and other collaboratorsCompletedBenign Prostatic HyperplasiaChina
-
Bioaraba Health Research InstituteCompletedBenign Prostatic HyperplasiaSpain
Clinical Trials on Digital Rectal Exam
-
UNC Lineberger Comprehensive Cancer CenterGE HealthcareCompleted
-
Mayo ClinicCompletedCervical DilationUnited States
-
Ministry of Health, ThailandCompletedDiabetic RetinopathyThailand
-
Felix GutierrezHospital Clinic of Barcelona; Hospital General Universitario Elche; Germans Trias... and other collaboratorsRecruiting
-
St. Luke's Medical Center, PhilippinesPhilippine Board of Urology; Philippine Urology Residents AssociationCompletedBenign Prostatic Hyperplasia | Prostate Cancer | ProstatitisPhilippines
-
Rabin Medical CenterUnknownLynch Syndrome | BRCA1 Syndrome | BRCA2 SyndromeIsrael
-
University of PennsylvaniaCompleted
-
Tepecik Training and Research HospitalCompletedNausea | Defecation Disorder | Paralytic IleusTurkey
-
Campbell GrantTerminatedOveractive BladderUnited States